Plasma Derived Medicinal Products (PDMPs)

PDMPs are Plasma-derived medicinal products, made by industry out of donated plasma.

Plasma derived medicinal products (PDMPs) are prepared industrially from human plasma by pharmaceutical companies and are life-saving therapeutics for large communities of patients.

PDMPs are used in very different circumstances:

  • For people with primary immunodeficiencies (immunoglobulin)
  • For patients suffering from haemophilia  and other bleeding disorders
  • For patients with antitrypsin deficiency
  • For people diagnosed with Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating neuropathy (CIDP) and multifocal motor neuropathy (MMN)
  • To stop a crisis in hereditary angioedema
  • In end stage liver failure (cirrhosis)
  • In shock, trauma and burn emergencies,
    among other uses.

List of PDMPs

For primary immunodeficiencies:

  • Intravenous immunoglobulin: 5%, 10%,
  • Subcutaneous immunoglobulin: 10%, 16%, 16,5%, 20%,

For haemophilia:

  • Plasma- derived Factor Concentrates: factors XIII, II, VII, IX, X

For alpha-1 antitrypsin deficiency:

  • Human alpha1-proteinase inhibitor

For Guillain-Barré-Sydrome:

  • Intravenous immunoglobuline
For chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy:
  • Intravenous immunoglobuline / Subcutanous immunoglobulin
Systemic treatment:
  • Albumin
Go To Plasma